Make an Appointment
-
Vantage Oncology Center for Radiation Therapy of Beverly Hills9229 Wilshire Blvd, Beverly Hills, CA 90210 map
Dr. May-Lin Tao is a board certified Radiation Oncologist. Vantage Oncology provides quality, personalized cancer care in a community setting.
Vantage Oncology Center for Radiation Therapy of Beverly Hills
Accepting New Patients?
Yes, Dr. May Lin Tao is accepting new patients at this office.
Phone
Address
9229 Wilshire Blvd, Beverly Hills, CA 90210
Office Details
Insurance Accepted
Please contact the doctor’s office to inquire about insurance.
Bio
Dr. Lin Tao has one office in California where she specializes in Oncology and Hematology / Oncology.
Dr. Lin Tao works with two doctors including Dr. Henry Yampolsky and Dr. Christopher Rose.
Specialties
-
Oncology
As an oncologist, Dr. Lin Tao is trained to diagnose and treat all types and forms of cancer. Dr. Lin Tao may employ a variety of diagnostic tests such as biopsies, imaging tests, endoscopic tests and laboratory tests. She may offer treatment techniques such as chemotherapy or radiotherapy to combat the spread of cancer. Dr. Lin Tao may also provide emotional and palliative care, ensuring patients experience the highest quality of life possible.
-
Hematology / Oncology
As a hematologist / oncologist in California, Dr. Lin Tao is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Lin Tao may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Lin Tao may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
Languages Spoken
- English
Links & Social Media
Latest Oncology News
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
Incontinence Drug May Cut Hot Flashes in Breast Cancer SurvivorsSteven Reinberg, HealthDay Reporter, Dec 7, 2018 at 9:00 AM
-
Healthy Lifestyle Lowers Odds of Breast Cancer's ReturnRobert Preidt, Dec 7, 2018 at 9:00 AM